To The Moon

📊 Market Recap As of the close on October 30, 2026 (Eastern Time), 'CBRS' settled at $109.18, down -5.19% for the session, with intraday range of $104.18 to $109.30. The stock now sits roughly 72% below its 52-week high of $386.34 and just above its newly established 52-week low of $104.18, signaling a fragile repair phase after a prolonged drawdown. 🚀 Key Drivers Oracle Deal Profit-Taking: The earlier announcement to integrate Cerebras AI inference services into Oracle Cloud Infrastructure briefly lifted shares by over 8%, but the latest sessions show sustained profit-taking and fading momentum. Short-Seller Pressure: Pre-market and intraday short-selling news resurfaced on October 30, shifting sentiment toward caution and accelerating the sell-off below the $110 level. Target Price Cut O

📊 Market Recap As of October 30, 2026 (America/New_York), 'DELL' closed at $424.30, plunging -10.77% (-$51.21) on massive volume of 10.47 million shares. The stock now sits roughly 28.8% below its 52-week high of $595.51, wiping out most of its recent AI-driven gains. 🚀 Key Drivers AI Hardware Selloff: A broad rout in semiconductor and PC-related names pressured DELL, with Intel's historic -29% collapse triggering a sector-wide 'sell first, ask questions later' reaction. Barclays Downgrade Echo: Barclays recently cut DELL to Equal Weight with a $574 target, reinforcing caution around AI server margin sustainability and order visibility. Valuation Reset: The sharp drop reflects derating from elevated forward multiples as investors reassess growth durability in the face of intensifying AI co

📊 Market Recap Vertiv Holdings LLC ('VRT') closed at $232.50 on October 31, 2026, down -5.46% with a trading volume of 7.63 million shares. The stock is now approximately 38.8% below its 52-week high of $379.94, reflecting a sharp cooling-off phase after an initial post-earnings surge. The pre-market price of $231.50 and after-hours price of $233.00 both pointed to continued volatility around the closing level, as investors digested the company's stronger-than-expected Q3 results against a backdrop of elevated valuation and profit-taking pressure. 🚀 Key Drivers Blowout Q3 Earnings: Vertiv reported Q3 revenue of $4.313 billion, up 61% year-over-year and well above the consensus estimate of $3.760 billion. Adjusted EPS came in at $2.21, exceeding the expected $1.83, while organic orders grew

📊 Market Recap As of October 31, 2026, 'PLTR' closed at $184.11, down -6.27% for the session, marking a sharp pullback from the previous close of $196.42. The stock now trades roughly -13.5% below its 52-week high of $212.94, with intraday volatility widening to a 6.67% amplitude as sellers took control near the $193.92 high and pushed price toward the $180.81 low. Momentum has clearly deteriorated in the short term. The decline came on elevated turnover, with trading volume reaching 26.96 million shares and a volume ratio of 1.42, indicating distribution rather than quiet consolidation. Support near $180 is now the immediate line in the sand, while resistance overhead sits at $195.90. 🚀 Key Drivers Profit-taking after AI-led rally: 'PLTR' had been riding strong AI and government software

📊 Market Recap As of October 31, 2026, 'NFLX' closed at $62.08, up a marginal +0.05% on the day. The stock remains under heavy pressure, trading just 1.1% above its 52-week low of $61.39 and approximately 46.8% below its 52-week high of $116.73. The recent breakdown followed a disappointing Q4 outlook that triggered a slide toward multi-year support. 🚀 Key Drivers Q4 Guidance Miss: Netflix issued a conservative Q4 EPS forecast of $0.67 on revenue of $13.44 billion, both below consensus expectations, fueling the post-earnings selloff. Ad Revenue Downgrade: Full-year 2026 advertising revenue guidance was trimmed by roughly $300 million to about $2.7 billion, raising concerns over monetization momentum. Analyst Divergence: Wall Street remains split after Q3 results, with some citing competiti

📊 Market Recap As of October 31, 2026 (ET), Moderna, Inc. ('MRNA') closed at $221.72, down -0.47% from the previous session's $222.76. The stock remains roughly 12.9% below its 52-week high of $254.48, while still up more than 650% year-to-date. The session's range of $217.22 to $227.81 shows fading selling pressure after the sharp October 23 plunge on the melanoma vaccine data leak, with buyers stepping in near the $217 area. 🚀 Key Drivers Cancer Vaccine Data Leak Fallout: The early leak of INTerpath-001 Phase III data triggered a record one-day drop of over 26% intraday, but the stock stabilized as Merck and Moderna confirmed full results would be formally released. ESMO Catalyst Ahead: The upcoming ESMO meeting and the release of complete Phase III data for the personalized mRNA cancer

📊 Market Recap As of the latest close on October 31, 2026 (ET), 'COHR' settled at $210.32, tumbling -11.34% from the prior session's $237.22. The stock now sits approximately 52.2% below its 52-week high of $440.00, while still trading well above its 52-week low of $123.75. Intraday action was extremely volatile: prices swung from an open of $217.14 to a high of $222.62 before collapsing to a low of $203.87, an amplitude of 7.90%. Volume surged to 11.91 million shares with a volume ratio of 1.69, indicating intense distribution pressure. 🚀 Key Drivers Technical Breakdown: The single-day -11.34% plunge pushed 'COHR' through multiple short-term support levels, with closing price dangerously close to the primary support of $205.72 as selling accelerated into the close. Capital Outflow: Five-d

📊 Market Recap As of October 30, 2026 (Eastern Time), 'STX' closed at $644.58, a sharp decline of -7.98% on the day. The stock opened at $652.00 and hit an intraday low of $625.30 before a weak rebound. The closing price is now 43.7% below its 52-week high of $1,145.00, reflecting intense profit-taking after a massive run-up in the AI storage theme. 🚀 Key Drivers Earnings Miss Sentiment: Despite the company reporting positive preliminary results, the market reacted violently to the downside, with 'STX' falling nearly 8% as investors locked in gains amid fears of AI capex slowdown. AI Storage Valuation Reset: Peer comparison with SK Hynix showed a stark divergence—Hynix rallied on strong HBM guidance, while 'STX' was sold off, suggesting investors are rotating away from traditional HDD expo

📊 Market Recap As of October 31, 2026, 'DRAM' closed at $48.01, down -7.23% from its previous close of $51.75. The price is now approximately 41% below its 52-week high of $81.34, while remaining about 84% above its 52-week low of $26.14. The sharp decline on elevated volume signals a decisive shift in short-term momentum, with sellers firmly in control following a failed attempt to hold above the $50 psychological level. 🚀 Key Drivers Memory Sector Weakness: Semiconductor and memory-related stocks faced broad selling pressure, with renewed concerns over AI investment weighing on the sector despite strong earnings elsewhere. Capital Outflows: Daily capital flow data shows total outflows of $861 million versus inflows of $782 million, with large orders contributing $132 million in net selli

📊 Market Recap 'MSTR' closed at $130.51 on October 31, plunging -7.84% from its previous close of $141.62. The stock now sits 52.8% below its 52-week high of $276.32, with intraday trading ranging from $124.06 to $134.51 on elevated volume of 33.88 million shares and a volume ratio of 2.40. The sharp rejection from $148.85 resistance and clean break below the $141 pivot confirm that near-term momentum has decisively shifted bearish. 🚀 Key Drivers Earnings Disappointment: Strategy reported strong earnings growth but shares fell 5% pre-market, as investors focused on shrinking bitcoin per share metrics despite $21 billion in unrealized gains. Bitcoin Correlation Drag: The stock trades as a leveraged bitcoin proxy, and any softness in BTC spot prices immediately compresses MSTR's premium to i